Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Albendazole Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Capsule
  • 1.3.3 Tablet
• 1.4 Market Segment by Application
  • 1.4.1 Global Albendazole Market Share by Application (2019-2025)
  • 1.4.2 Pinworm Infection Treatment
  • 1.4.3 Ascaris Infection Treatment
  • 1.4.4 Other Parasitic Infections Treatment
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Albendazole Market Size
  • 2.1.1 Global Albendazole Revenue 2014-2025
  • 2.1.2 Global Albendazole Sales 2014-2025
• 2.2 Albendazole Growth Rate by Regions
  • 2.2.1 Global Albendazole Sales by Regions 2014-2019
  • 2.2.2 Global Albendazole Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Albendazole Sales by Manufacturers
  • 3.1.1 Albendazole Sales by Manufacturers 2014-2019
  • 3.1.2 Albendazole Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Albendazole Revenue by Manufacturers (2014-2019)
  • 3.2.2 Albendazole Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Albendazole Market Concentration Ratio (CR5 and HHI)
• 3.3 Albendazole Price by Manufacturers
• 3.4 Key Manufacturers Albendazole Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Albendazole Market
• 3.6 Key Manufacturers Albendazole Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Capsule Sales and Revenue (2014-2019)
  • 4.1.2 Tablet Sales and Revenue (2014-2019)
• 4.2 Global Albendazole Sales Market Share by Type
• 4.3 Global Albendazole Revenue Market Share by Type
• 4.4 Albendazole Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Albendazole Sales by Application

6 United States

• 6.1 United States Albendazole Breakdown Data by Company
• 6.2 United States Albendazole Breakdown Data by Type
• 6.3 United States Albendazole Breakdown Data by Application

7 European Union

• 7.1 European Union Albendazole Breakdown Data by Company
• 7.2 European Union Albendazole Breakdown Data by Type
• 7.3 European Union Albendazole Breakdown Data by Application

8 China

• 8.1 China Albendazole Breakdown Data by Company
• 8.2 China Albendazole Breakdown Data by Type
• 8.3 China Albendazole Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Albendazole Breakdown Data by Company
• 9.2 Rest of World Albendazole Breakdown Data by Type
• 9.3 Rest of World Albendazole Breakdown Data by Application
• 9.4 Rest of World Albendazole Breakdown Data by Countries
  • 9.4.1 Rest of World Albendazole Sales by Countries
  • 9.4.2 Rest of World Albendazole Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 CHANGZHOU YABANG
  • 10.1.1 CHANGZHOU YABANG Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Albendazole
  • 10.1.4 Albendazole Product Introduction
  • 10.1.5 CHANGZHOU YABANG Recent Development
• 10.2 GlaxoSmithKline
  • 10.2.1 GlaxoSmithKline Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Albendazole
  • 10.2.4 Albendazole Product Introduction
  • 10.2.5 GlaxoSmithKline Recent Development
• 10.3 Huazhong Pharmaceutical
  • 10.3.1 Huazhong Pharmaceutical Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Albendazole
  • 10.3.4 Albendazole Product Introduction
  • 10.3.5 Huazhong Pharmaceutical Recent Development
• 10.4 Hubei Zhongjia-chem Pharmaceutical
  • 10.4.1 Hubei Zhongjia-chem Pharmaceutical Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Albendazole
  • 10.4.4 Albendazole Product Introduction
  • 10.4.5 Hubei Zhongjia-chem Pharmaceutical Recent Development
• 10.5 HUBEI KEYI
  • 10.5.1 HUBEI KEYI Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Albendazole
  • 10.5.4 Albendazole Product Introduction
  • 10.5.5 HUBEI KEYI Recent Development
• 10.6 Sequent Scientifi
  • 10.6.1 Sequent Scientifi Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Albendazole
  • 10.6.4 Albendazole Product Introduction
  • 10.6.5 Sequent Scientifi Recent Development
• 10.7 Lasa Laboratory Pvt Ltd
  • 10.7.1 Lasa Laboratory Pvt Ltd Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Albendazole
  • 10.7.4 Albendazole Product Introduction
  • 10.7.5 Lasa Laboratory Pvt Ltd Recent Development
• 10.8 K.A.Malle Pharmaceuticals
  • 10.8.1 K.A.Malle Pharmaceuticals Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Albendazole
  • 10.8.4 Albendazole Product Introduction
  • 10.8.5 K.A.Malle Pharmaceuticals Recent Development
• 10.9 Supharma Chem
  • 10.9.1 Supharma Chem Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Albendazole
  • 10.9.4 Albendazole Product Introduction
  • 10.9.5 Supharma Chem Recent Development
• 10.10 Salius Pharma
  • 10.10.1 Salius Pharma Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Albendazole
  • 10.10.4 Albendazole Product Introduction
  • 10.10.5 Salius Pharma Recent Development
• 10.11 Fredun Pharmaceuticals Ltd
• 10.12 Ashish life Science Pvt. Ltd.
• 10.13 AdvacarePharma
• 10.14 MANAV DRUGS
• 10.15 Leo Bio-Care Pvt.

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Albendazole Sales Channels
  • 11.2.2 Albendazole Distributors
• 11.3 Albendazole Customers

12 Market Forecast

• 12.1 Global Albendazole Sales and Revenue Forecast 2019-2025
• 12.2 Global Albendazole Sales Forecast by Type
• 12.3 Global Albendazole Sales Forecast by Application
• 12.4 Albendazole Forecast by Regions
  • 12.4.1 Global Albendazole Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Albendazole Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Albendazole is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Albendazole.

This report studies the global market size of Albendazole, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Albendazole sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
CHANGZHOU YABANG
GlaxoSmithKline
Huazhong Pharmaceutical
Hubei Zhongjia-chem Pharmaceutical
HUBEI KEYI
Sequent Scientifi
Lasa Laboratory Pvt Ltd
K.A.Malle Pharmaceuticals
Supharma Chem
Salius Pharma
Fredun Pharmaceuticals Ltd
Ashish life Science Pvt. Ltd.
AdvacarePharma
MANAV DRUGS
Leo Bio-Care Pvt.

Market Segment by Product Type
Capsule
Tablet

Market Segment by Application
Pinworm Infection Treatment
Ascaris Infection Treatment
Other Parasitic Infections Treatment

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Albendazole status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Albendazole manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Albendazole are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025